We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Surveillance Trial Offers Peace of Mind for High-risk BRCA-carriers

News   Aug 23, 2018 | Original story sourced from University College Hospitals London

 
Avoiding Late Diagnosis of Ovarian Cancer

The ALDO (Avoiding Late Diagnosis of Ovarian Cancer) project is a partnership between UCLH Cancer Collaborative and Abcodia Ltd. The project was conceived as part of the Cancer Vanguard’s challenge to industry in 2017, to work with the NHS on projects to improve the early diagnosis of cancer. Photo credit: Pixabay

 
 
 

RELATED ARTICLES

Genetics Won’t Influence Your Dental Health – But Your Mother’s Diet May

News

A new study has found genetic makeup does not predispose people to tooth decay, however the research did find that children with overweight mothers are more likely to have cavities.

READ MORE

Proteogenomics Holds the Key to Unlocking Cancer Therapies

News

Analyzing both the entire set of genes and all the proteins produced by colon cancer tissues from patient samples has revealed a more comprehensive view of the tumor that points at novel cancer biological mechanisms and possible new therapeutic strategies.

READ MORE

Personalized Cancer Therapy Trial Shows Encouraging Results

News

A newly published study has demonstrated the potential of using transcriptomics to help get cancer patients on treatments they're most likely to benefit from.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE